Health committee  Yes, there was one paper in particular in a Canadian context, but it was going back to the mid-1990s. It was a very small sample size. It was very targeted to one single organization. It was over 20 years old. Even by PBO standards, we thought that it was probably precarious to b

Health committee  We did. It was an exhaustive literature review.

Health committee  The reason that the parliamentary budget officer identified our number is that we call it a “balance number”. On the other side, of course, we end up having, for the 2015-16 savings estimate, a complete immediate phase-in of the actual negotiated savings with respect to negotiati

Health committee  As well, looking at that, drug prices are of course moving targets. We have probably the best dataset available within the public sector right now with respect to the composition of drugs and drug consumption. That is changing dynamically over time. Going back to a point I made

Health committee  No. Again, for the purposes of the mandate of the committee, I think our report is an excellent starting point in terms of trying to identify some of the major cost drivers and factors that parliamentarians need to consider if they decide they want to move forward on solving some

Health committee  No, we haven't. We have done work with respect to our economic and fiscal outlook and do regular work on an ongoing basis, particularly in looking at the accuracy of those forecasts five years out. With respect to more comprehensive costing reports, we haven't done anything on